Trouble shooting accelerator system for implantable drug delivery pumps

• US 7,089,783 B2
• Filed: 05/31/2005
• Issued: 08/15/2006
• Est. Priority Date: 01/22/2003
• Status: Expired due to Term

• Current Assignee: Codman & Shurtleff Incorporated (Johnson & Johnson)
• Original Assignee: Codman & Shurtleff Incorporated (Johnson & Johnson)
• Inventors: Mastrorio, Brooke W., Beardsley, Timothy, Ludin, Lev
• Primary Examiner(s): GARBER, CHARLES D
• Application Number:
  US11/141,066
• Publication Number:
  US 20050229683A1
• Time in Patent Office: 441 Days
• Field of Search: 73/40, 73/407, 604/111
• US Class Current: 73/40.7
• CPC Class Codes: A61M 2205/15 Detection of leaks
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/14586 pressurised by means of a flexible diaphragm
• CPC Class Codes: A61M 5/16827 controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths infusion of multiple fluids without using a controller A61M5/1407
• CPC Class Codes: A61M 5/16831 Monitoring, detecting, signalling or eliminating infusion flow anomalies low-level float-valves causing cut-off A61M5/40; indicating or recording presence, absence or direction of flow in general G01P13/0066
• CPC Class Codes: A61M 5/16881 Regulating valves on-off valves, e.g. clamps A61M39/28

Abstract

An implantable pump and methods for detecting leaks in an implantable pump are provided. In one embodiment, the implantable drug pump includes a housing having at least one inlet port and an outlet port formed therein. The outlet port is adapted to communicate with a catheter for delivering fluid to a patient'"'"'s body, and the inlet port(s) are effective to deliver fluid into the housing. The housing further includes at least one reservoir disposed therein and effective to contain a fluid. In use, the pump preferably includes a fluid having one or more drugs disposed in at least one of the reservoirs, and a radiolucent fluid disposed in one of the reservoirs. A user programmable control mechanism is coupled to the drug pump and is effective to selectively control movement of the valves between the open and closed positions.

Claims

1. A method for detecting a leak in an implantable drug pump, comprising:

causing a first valve of an implantable drug pump to move from an open position, in which fluid can flow from a first reservoir formed in a housing of the implantable drug pump to an outlet port formed in the housing of the implantable drug pump, to a closed position, in which fluid is prevented from flowing from the first reservoir to the outlet port;

causing a second valve to move from a closed position, in which fluid is prevented from flowing from a second reservoir formed in the housing of the implantable drug pump to the outlet port, to an open position, in which fluid is free to flow from the second reservoir to the outlet port;

actuating a driver mechanism to cause a radiolucent fluid disposed within the second reservoir to flow through the second valve and into the outlet port to be delivered to a patient'"'"'s body; and

radiographically viewing the radiolucent fluid flowing through the implantable drug pump to determine if any leaks exist in the implantable drug pump and structures connected to the implantable drug pump;

wherein the implantable drug pump includes a first inlet port in communication with the first reservoir, and a second inlet port in communication with the second reservoir;

wherein, prior to the step of causing a second valve to move from a closed position to an open position, the radiolucent fluid is introduced into the second reservoir through the second inlet port.

2. The method of claim 1, further comprising a catheter connected to the outlet port and adapted to deliver a fluid to a patient'"'"'s body, and wherein the flow of radiolucent fluid through the pump and the catheter is radiographically viewed to determine if any leaks exist in the implantable drug pump and the catheter.

3. The method of claim 1, wherein the radiolucent fluid comprises a marking agent.

4. The method of claim 1, wherein the driver mechanism of the implantable drug pump is selected from the group consisting of a compression spring, a propellant gas, and an electromechanical actuator.

5. The implantable drug pump of claim 1, wherein the driver mechanism of the implantable drug pump is adapted to apply a force to at least one of the first and second reservoirs to cause fluid disposed within the reservoir to be forced through one of the first and second valves and the outlet port.

6. The method of claim 1, wherein the inlet port of the implantable drug pump comprises a bolus port adapted to allow a drug to be delivered directly to the outlet port.

7. The method of claim 1, wherein the radiolucent fluid comprises a mixture of a marking agent and sodium chloride.

8. The method of claim 1, wherein the implantable drug pump further comprises a user programmable control mechanism coupled to the drug pump and effective to selectively control movement of each of the first and second valves between the open and closed positions.